Vivitrol Alternatives Compared
| Vivitrol (naltrexone) | Suboxone (buprenorphine / naloxone) | Buprenorphine / naloxone |
|
|---|
| Vivitrol (naltrexone) | Suboxone (buprenorphine / naloxone) | Buprenorphine / naloxone |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Vivitrol s a brand name for naltrexone injection that is used to treat alcohol dependence or for preventing the relapse to opioid dependence following opioid (narcotic) detoxification, alongside... View more |
Prescription only
Suboxone is a combination medicine containing buprenorphine and naloxone that is used to treat adults addicted to opioid medications. It should be used in conjunction with a complete treatment... View more |
Prescription only
Buprenorphine/naloxone is a combination opioid/opioid antagonist tablet which helps to suppress opioid withdrawal symptoms and is used for the maintenance treatment of opioid drug dependence... View more |
Related suggestions Opioid Use Disorder
|
|||||||||||||||||||||||
| More about Vivitrol (naltrexone) | More about Suboxone (buprenorphine / naloxone) | More about Buprenorphine / naloxone | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Vivitrol has an average rating of 7.5 out of 10 from a total of 204 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 20% reported a negative effect. |
Suboxone has an average rating of 8.5 out of 10 from a total of 731 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 7% reported a negative effect. |
Buprenorphine / naloxone has an average rating of 7.7 out of 10 from a total of 1134 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Vivitrol side effects |
View all Suboxone side effects |
|
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Vivitrol prices |
View all Suboxone prices |
View all Buprenorphine / naloxone prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Other buprenorphine / naloxone brands include: Zubsolv | Suboxone, Zubsolv | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
10 hours |
37 hours |
37 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 355 drugs are known to interact with Vivitrol:
|
A total of 734 drugs are known to interact with Suboxone:
|
A total of 734 drugs are known to interact with Buprenorphine / naloxone:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
April 13, 2006 |
October 08, 2002 |
October 08, 2002 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.